The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pruritus Therapeutics Market Research Report 2025
Synopsis
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
The global Pruritus Therapeutics market was valued at US$ 13680 million in 2023 and is anticipated to reach US$ 18060 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
Report Scope
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pruritus Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Segment by Type
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Segment by Application
External Use
Oral
Injection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
The global Pruritus Therapeutics market was valued at US$ 13680 million in 2023 and is anticipated to reach US$ 18060 million by 2030, witnessing a CAGR of 4.0% during the forecast period 2024-2030.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
Report Scope
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pruritus Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pruritus Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Segment by Type
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
Segment by Application
External Use
Oral
Injection
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pruritus Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pruritus Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pruritus Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pruritus Therapeutics Market Perspective (2019-2030)
2.2 Pruritus Therapeutics Growth Trends by Region
2.2.1 Global Pruritus Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pruritus Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Pruritus Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Pruritus Therapeutics Market Dynamics
2.3.1 Pruritus Therapeutics Industry Trends
2.3.2 Pruritus Therapeutics Market Drivers
2.3.3 Pruritus Therapeutics Market Challenges
2.3.4 Pruritus Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pruritus Therapeutics Players by Revenue
3.1.1 Global Top Pruritus Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pruritus Therapeutics Revenue
3.4 Global Pruritus Therapeutics Market Concentration Ratio
3.4.1 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pruritus Therapeutics Revenue in 2023
3.5 Pruritus Therapeutics Key Players Head office and Area Served
3.6 Key Players Pruritus Therapeutics Product Solution and Service
3.7 Date of Enter into Pruritus Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pruritus Therapeutics Breakdown Data by Type
4.1 Global Pruritus Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2025-2030)
5 Pruritus Therapeutics Breakdown Data by Application
5.1 Global Pruritus Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pruritus Therapeutics Market Size (2019-2030)
6.2 North America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pruritus Therapeutics Market Size by Country (2019-2024)
6.4 North America Pruritus Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pruritus Therapeutics Market Size (2019-2030)
7.2 Europe Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pruritus Therapeutics Market Size by Country (2019-2024)
7.4 Europe Pruritus Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pruritus Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Pruritus Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pruritus Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Pruritus Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pruritus Therapeutics Market Size (2019-2030)
9.2 Latin America Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pruritus Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Pruritus Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pruritus Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Pruritus Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pruritus Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Pruritus Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J&J
11.1.1 J&J Company Detail
11.1.2 J&J Business Overview
11.1.3 J&J Pruritus Therapeutics Introduction
11.1.4 J&J Revenue in Pruritus Therapeutics Business (2019-2024)
11.1.5 J&J Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Pruritus Therapeutics Introduction
11.2.4 Abbott Revenue in Pruritus Therapeutics Business (2019-2024)
11.2.5 Abbott Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Pruritus Therapeutics Introduction
11.3.4 Amgen Revenue in Pruritus Therapeutics Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 LEO Pharma
11.4.1 LEO Pharma Company Detail
11.4.2 LEO Pharma Business Overview
11.4.3 LEO Pharma Pruritus Therapeutics Introduction
11.4.4 LEO Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
11.4.5 LEO Pharma Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Pruritus Therapeutics Introduction
11.5.4 Novartis Revenue in Pruritus Therapeutics Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Pruritus Therapeutics Introduction
11.6.4 Bayer Revenue in Pruritus Therapeutics Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Pruritus Therapeutics Introduction
11.7.4 Pfizer Revenue in Pruritus Therapeutics Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 UCB Pharma
11.8.1 UCB Pharma Company Detail
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Pruritus Therapeutics Introduction
11.8.4 UCB Pharma Revenue in Pruritus Therapeutics Business (2019-2024)
11.8.5 UCB Pharma Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Pruritus Therapeutics Introduction
11.9.4 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2019-2024)
11.9.5 GlaxoSmithKline Recent Development
11.10 Galderma
11.10.1 Galderma Company Detail
11.10.2 Galderma Business Overview
11.10.3 Galderma Pruritus Therapeutics Introduction
11.10.4 Galderma Revenue in Pruritus Therapeutics Business (2019-2024)
11.10.5 Galderma Recent Development
11.11 Huapont
11.11.1 Huapont Company Detail
11.11.2 Huapont Business Overview
11.11.3 Huapont Pruritus Therapeutics Introduction
11.11.4 Huapont Revenue in Pruritus Therapeutics Business (2019-2024)
11.11.5 Huapont Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
